VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-1.04%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$165M
AUM Growth
-$4.08M
(-2.4%)
Cap. Flow
+$1.01M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
6.09%
Holding
488
New
53
Increased
73
Reduced
307
Closed
54
Top Buys
| 1 |
Halliburton
HAL
|
$819K |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$814K |
| 3 |
Steel Dynamics
STLD
|
$798K |
| 4 |
Caterpillar
CAT
|
$792K |
| 5 |
Booking.com
BKNG
|
$789K |
Top Sells
| 1 |
Netflix
NFLX
|
$1.05M |
| 2 |
Vulcan Materials
VMC
|
$1.01M |
| 3 |
CoStar Group
CSGP
|
$998K |
| 4 |
Eli Lilly
LLY
|
$967K |
| 5 |
Ingersoll Rand
IR
|
$913K |
Sector Composition
| 1 | Healthcare | 18.63% |
| 2 | Financials | 17.26% |
| 3 | Technology | 14.89% |
| 4 | Energy | 9.42% |
| 5 | Consumer Discretionary | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Legend Biotech
LEGN
$6.66B
| $296K | 0.18% |
4,409
-573
| -12% | -$38.5K |
|
202
Gilead Sciences
GILD
$143B
| $295K | 0.18% |
3,941
-467
| -11% | -$35K |
|
203
Agios Pharmaceuticals
AGIO
$2.09B
| $293K | 0.18% |
11,823
-1,532
| -11% | -$37.9K |
|
|
CEN
204
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
| $290K | 0.18% |
+13,699
| New | +$290K |
|
205
Incyte
INCY
$16.9B
| $286K | 0.17% |
4,951
-11,114
| -69% | -$642K |
|
206
BioMarin Pharmaceuticals
BMRN
$11.1B
| $285K | 0.17% |
3,221
-419
| -12% | -$37.1K |
|
207
Sarepta Therapeutics
SRPT
$1.96B
| $283K | 0.17% |
2,334
-301
| -11% | -$36.5K |
|
208
ADMA Biologics
ADMA
$4.03B
| $280K | 0.17% |
78,224
-10,111
| -11% | -$36.2K |
|
209
Harmony Biosciences
HRMY
$2.07B
| $279K | 0.17% |
8,510
-1,099
| -11% | -$36K |
|
210
Amicus Therapeutics
FOLD
$2.46B
| $278K | 0.17% |
22,877
-2,959
| -11% | -$36K |
|
211
Immunocore
IMCR
$1.87B
| $273K | 0.17% |
5,265
-684
| -11% | -$35.5K |
|
|
DCPH
212
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $273K | 0.17% |
21,460
-2,773
| -11% | -$35.3K |
|
|
IMGN
213
DELISTED
Immunogen Inc
IMGN
| $273K | 0.17% |
17,174
-2,218
| -11% | -$35.2K |
|
214
Alnylam Pharmaceuticals
ALNY
$59.4B
| $271K | 0.16% |
1,533
-198
| -11% | -$35.1K |
|
215
BioCryst Pharmaceuticals
BCRX
$1.74B
| $271K | 0.16% |
38,321
-4,957
| -11% | -$35.1K |
|
216
Zai Lab
ZLAB
$3.42B
| $267K | 0.16% |
10,998
-1,425
| -11% | -$34.6K |
|
217
Ironwood Pharmaceuticals
IRWD
$188M
| $265K | 0.16% |
27,538
-3,559
| -11% | -$34.3K |
|
218
Axsome Therapeutics
AXSM
$6.25B
| $263K | 0.16% |
3,762
-485
| -11% | -$33.9K |
|
219
Acadia Pharmaceuticals
ACAD
$4.26B
| $263K | 0.16% |
12,605
-1,630
| -11% | -$34K |
|
|
ONC
220
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $262K | 0.16% |
1,459
-192
| -12% | -$34.5K |
|
221
Biogen
BIIB
$20.6B
| $261K | 0.16% |
1,016
-129
| -11% | -$33.2K |
|
|
BPMC
222
DELISTED
Blueprint Medicines
BPMC
| $260K | 0.16% |
5,179
-669
| -11% | -$33.6K |
|
|
VRN
223
DELISTED
Veren
VRN
| $254K | 0.15% |
30,645
-2,406
| -7% | -$20K |
|
224
Theravance Biopharma
TBPH
$703M
| $252K | 0.15% |
29,232
-3,777
| -11% | -$32.6K |
|
225
SunCoke Energy
SXC
$667M
| $252K | 0.15% |
24,853
-685
| -3% | -$6.95K |
|